Table of Content

1 Branded Generics Market Overview
1.1 Product Overview and Scope of Branded Generics
1.2 Branded Generics Segment by Type
1.2.1 Global Branded Generics Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Parenteral
1.2.4 Topical
1.2.5 Other
1.3 Branded Generics Segment by Application
1.3.1 Global Branded Generics Market Value by Application: (2024-2034)
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Diabetes
1.3.5 Neurology
1.3.6 Gastrointestinal Diseases
1.3.7 Others
1.4 Global Branded Generics Market Size Estimates and Forecasts
1.4.1 Global Branded Generics Revenue 2018-2029
1.4.2 Global Branded Generics Sales 2018-2029
1.4.3 Global Branded Generics Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Branded Generics Market Competition by Manufacturers
2.1 Global Branded Generics Sales Market Share by Manufacturers (2018-2024)
2.2 Global Branded Generics Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Branded Generics Average Price by Manufacturers (2018-2024)
2.4 Global Branded Generics Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Branded Generics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Branded Generics, Product Type & Application
2.7 Branded Generics Market Competitive Situation and Trends
2.7.1 Branded Generics Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Branded Generics Players Market Share by Revenue
2.7.3 Global Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Branded Generics Retrospective Market Scenario by Region
3.1 Global Branded Generics Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Branded Generics Global Branded Generics Sales by Region: 2018-2029
3.2.1 Global Branded Generics Sales by Region: 2018-2024
3.2.2 Global Branded Generics Sales by Region: 2024-2029
3.3 Global Branded Generics Global Branded Generics Revenue by Region: 2018-2029
3.3.1 Global Branded Generics Revenue by Region: 2018-2024
3.3.2 Global Branded Generics Revenue by Region: 2024-2029
3.4 North America Branded Generics Market Facts & Figures by Country
3.4.1 North America Branded Generics Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Branded Generics Sales by Country (2018-2029)
3.4.3 North America Branded Generics Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Branded Generics Market Facts & Figures by Country
3.5.1 Europe Branded Generics Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Branded Generics Sales by Country (2018-2029)
3.5.3 Europe Branded Generics Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Branded Generics Market Facts & Figures by Country
3.6.1 Asia Pacific Branded Generics Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Branded Generics Sales by Country (2018-2029)
3.6.3 Asia Pacific Branded Generics Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Branded Generics Market Facts & Figures by Country
3.7.1 Latin America Branded Generics Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Branded Generics Sales by Country (2018-2029)
3.7.3 Latin America Branded Generics Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Branded Generics Market Facts & Figures by Country
3.8.1 Middle East and Africa Branded Generics Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Branded Generics Sales by Country (2018-2029)
3.8.3 Middle East and Africa Branded Generics Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Branded Generics Sales by Type (2018-2029)
4.1.1 Global Branded Generics Sales by Type (2018-2024)
4.1.2 Global Branded Generics Sales by Type (2024-2029)
4.1.3 Global Branded Generics Sales Market Share by Type (2018-2029)
4.2 Global Branded Generics Revenue by Type (2018-2029)
4.2.1 Global Branded Generics Revenue by Type (2018-2024)
4.2.2 Global Branded Generics Revenue by Type (2024-2029)
4.2.3 Global Branded Generics Revenue Market Share by Type (2018-2029)
4.3 Global Branded Generics Price by Type (2018-2029)
5 Segment by Application
5.1 Global Branded Generics Sales by Application (2018-2029)
5.1.1 Global Branded Generics Sales by Application (2018-2024)
5.1.2 Global Branded Generics Sales by Application (2024-2029)
5.1.3 Global Branded Generics Sales Market Share by Application (2018-2029)
5.2 Global Branded Generics Revenue by Application (2018-2029)
5.2.1 Global Branded Generics Revenue by Application (2018-2024)
5.2.2 Global Branded Generics Revenue by Application (2024-2029)
5.2.3 Global Branded Generics Revenue Market Share by Application (2018-2029)
5.3 Global Branded Generics Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Mylan NV
6.1.1 Mylan NV Corporation Information
6.1.2 Mylan NV Description and Business Overview
6.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Mylan NV Branded Generics Product Portfolio
6.1.5 Mylan NV Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Corporation Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Novartis AG Branded Generics Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Eva Pharmaceutical Industries
6.3.1 Eva Pharmaceutical Industries Corporation Information
6.3.2 Eva Pharmaceutical Industries Description and Business Overview
6.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Eva Pharmaceutical Industries Branded Generics Product Portfolio
6.3.5 Eva Pharmaceutical Industries Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Pfizer Branded Generics Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Sun Pharmaceutical Industries Branded Generics Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Aspen Pharmacare Holding
6.6.1 Aspen Pharmacare Holding Corporation Information
6.6.2 Aspen Pharmacare Holding Description and Business Overview
6.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Aspen Pharmacare Holding Branded Generics Product Portfolio
6.6.5 Aspen Pharmacare Holding Recent Developments/Updates
6.7 Abbott Laboratories
6.6.1 Abbott Laboratories Corporation Information
6.6.2 Abbott Laboratories Description and Business Overview
6.6.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abbott Laboratories Branded Generics Product Portfolio
6.7.5 Abbott Laboratories Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bausch Health Branded Generics Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Branded Generics Industry Chain Analysis
7.2 Branded Generics Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Branded Generics Production Mode & Process
7.4 Branded Generics Sales and Marketing
7.4.1 Branded Generics Sales Channels
7.4.2 Branded Generics Distributors
7.5 Branded Generics Customers
8 Branded Generics Market Dynamics
8.1 Branded Generics Industry Trends
8.2 Branded Generics Market Drivers
8.3 Branded Generics Market Challenges
8.4 Branded Generics Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Branded Generics Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Branded Generics Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Branded Generics Market Competitive Situation by Manufacturers in 2022
Table 4. Global Branded Generics Sales (K MT) of Key Manufacturers (2018-2024)
Table 5. Global Branded Generics Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Branded Generics Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Branded Generics Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Branded Generics Average Price (USD/MT) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Branded Generics, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Branded Generics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Branded Generics, Product Type & Application
Table 12. Global Key Manufacturers of Branded Generics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Branded Generics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Branded Generics as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Branded Generics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Branded Generics Sales by Region (2018-2024) & (K MT)
Table 18. Global Branded Generics Sales Market Share by Region (2018-2024)
Table 19. Global Branded Generics Sales by Region (2024-2029) & (K MT)
Table 20. Global Branded Generics Sales Market Share by Region (2024-2029)
Table 21. Global Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Branded Generics Revenue Market Share by Region (2018-2024)
Table 23. Global Branded Generics Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Branded Generics Revenue Market Share by Region (2024-2029)
Table 25. North America Branded Generics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Branded Generics Sales by Country (2018-2024) & (K MT)
Table 27. North America Branded Generics Sales by Country (2024-2029) & (K MT)
Table 28. North America Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Branded Generics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Branded Generics Sales by Country (2018-2024) & (K MT)
Table 32. Europe Branded Generics Sales by Country (2024-2029) & (K MT)
Table 33. Europe Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Branded Generics Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Branded Generics Sales by Region (2018-2024) & (K MT)
Table 37. Asia Pacific Branded Generics Sales by Region (2024-2029) & (K MT)
Table 38. Asia Pacific Branded Generics Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Branded Generics Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Branded Generics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Branded Generics Sales by Country (2018-2024) & (K MT)
Table 42. Latin America Branded Generics Sales by Country (2024-2029) & (K MT)
Table 43. Latin America Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Branded Generics Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Branded Generics Sales by Country (2018-2024) & (K MT)
Table 47. Middle East & Africa Branded Generics Sales by Country (2024-2029) & (K MT)
Table 48. Middle East & Africa Branded Generics Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Branded Generics Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Branded Generics Sales (K MT) by Type (2018-2024)
Table 51. Global Branded Generics Sales (K MT) by Type (2024-2029)
Table 52. Global Branded Generics Sales Market Share by Type (2018-2024)
Table 53. Global Branded Generics Sales Market Share by Type (2024-2029)
Table 54. Global Branded Generics Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Branded Generics Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Branded Generics Revenue Market Share by Type (2018-2024)
Table 57. Global Branded Generics Revenue Market Share by Type (2024-2029)
Table 58. Global Branded Generics Price (USD/MT) by Type (2018-2024)
Table 59. Global Branded Generics Price (USD/MT) by Type (2024-2029)
Table 60. Global Branded Generics Sales (K MT) by Application (2018-2024)
Table 61. Global Branded Generics Sales (K MT) by Application (2024-2029)
Table 62. Global Branded Generics Sales Market Share by Application (2018-2024)
Table 63. Global Branded Generics Sales Market Share by Application (2024-2029)
Table 64. Global Branded Generics Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Branded Generics Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Branded Generics Revenue Market Share by Application (2018-2024)
Table 67. Global Branded Generics Revenue Market Share by Application (2024-2029)
Table 68. Global Branded Generics Price (USD/MT) by Application (2018-2024)
Table 69. Global Branded Generics Price (USD/MT) by Application (2024-2029)
Table 70. Mylan NV Corporation Information
Table 71. Mylan NV Description and Business Overview
Table 72. Mylan NV Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 73. Mylan NV Branded Generics Product
Table 74. Mylan NV Recent Developments/Updates
Table 75. Novartis AG Corporation Information
Table 76. Novartis AG Description and Business Overview
Table 77. Novartis AG Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 78. Novartis AG Branded Generics Product
Table 79. Novartis AG Recent Developments/Updates
Table 80. Eva Pharmaceutical Industries Corporation Information
Table 81. Eva Pharmaceutical Industries Description and Business Overview
Table 82. Eva Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 83. Eva Pharmaceutical Industries Branded Generics Product
Table 84. Eva Pharmaceutical Industries Recent Developments/Updates
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 88. Pfizer Branded Generics Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Corporation Information
Table 91. Sun Pharmaceutical Industries Description and Business Overview
Table 92. Sun Pharmaceutical Industries Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 93. Sun Pharmaceutical Industries Branded Generics Product
Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
Table 95. Aspen Pharmacare Holding Corporation Information
Table 96. Aspen Pharmacare Holding Description and Business Overview
Table 97. Aspen Pharmacare Holding Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 98. Aspen Pharmacare Holding Branded Generics Product
Table 99. Aspen Pharmacare Holding Recent Developments/Updates
Table 100. Abbott Laboratories Corporation Information
Table 101. Abbott Laboratories Description and Business Overview
Table 102. Abbott Laboratories Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 103. Abbott Laboratories Branded Generics Product
Table 104. Abbott Laboratories Recent Developments/Updates
Table 105. Bausch Health Corporation Information
Table 106. Bausch Health Description and Business Overview
Table 107. Bausch Health Branded Generics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 108. Bausch Health Branded Generics Product
Table 109. Bausch Health Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Branded Generics Distributors List
Table 113. Branded Generics Customers List
Table 114. Branded Generics Market Trends
Table 115. Branded Generics Market Drivers
Table 116. Branded Generics Market Challenges
Table 117. Branded Generics Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Branded Generics
Figure 2. Global Branded Generics Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Branded Generics Market Share by Type in 2022 & 2029
Figure 4. Oral Product Picture
Figure 5. Parenteral Product Picture
Figure 6. Topical Product Picture
Figure 7. Other Product Picture
Figure 8. Global Branded Generics Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Branded Generics Market Share by Application in 2022 & 2029
Figure 10. Oncology
Figure 11. Cardiovascular Diseases
Figure 12. Diabetes
Figure 13. Neurology
Figure 14. Gastrointestinal Diseases
Figure 15. Others
Figure 16. Global Branded Generics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Branded Generics Market Size (2018-2029) & (US$ Million)
Figure 18. Global Branded Generics Sales (2018-2029) & (K MT)
Figure 19. Global Branded Generics Average Price (USD/MT) & (2018-2029)
Figure 20. Branded Generics Report Years Considered
Figure 21. Branded Generics Sales Share by Manufacturers in 2022
Figure 22. Global Branded Generics Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Branded Generics Players: Market Share by Revenue in 2022
Figure 24. Branded Generics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Branded Generics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Branded Generics Sales Market Share by Country (2018-2029)
Figure 27. North America Branded Generics Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Branded Generics Sales Market Share by Country (2018-2029)
Figure 31. Europe Branded Generics Revenue Market Share by Country (2018-2029)
Figure 32. Germany Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Branded Generics Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Branded Generics Revenue Market Share by Region (2018-2029)
Figure 39. China Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Branded Generics Sales Market Share by Country (2018-2029)
Figure 50. Latin America Branded Generics Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Branded Generics Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Branded Generics Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. U.A.E Branded Generics Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Branded Generics by Type (2018-2029)
Figure 60. Global Revenue Market Share of Branded Generics by Type (2018-2029)
Figure 61. Global Branded Generics Price (USD/MT) by Type (2018-2029)
Figure 62. Global Sales Market Share of Branded Generics by Application (2018-2029)
Figure 63. Global Revenue Market Share of Branded Generics by Application (2018-2029)
Figure 64. Global Branded Generics Price (USD/MT) by Application (2018-2029)
Figure 65. Branded Generics Value Chain
Figure 66. Branded Generics Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed